Uhlmann Price Securities, LLC Pfizer Inc Call Options Transaction History

Uhlmann Price Securities, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2025 Jul 29, 2025	SELL	$21.59 - $24.84 $6,477 - $7,452	-300 Reduced 27.27%	800 $278,000
Q1 2025 Jul 16, 2025	BUY	$25.01 - $27.13 $15,006 - $16,278	600 Added 120.0%	1,100 $486,000
Q4 2024 Jul 16, 2025	BUY	$24.8 - $30.19 $12,400 - $15,095	500 New	500 $368,000
Q3 2024 Jul 30, 2025	SELL	$27.7 - $31.39 $2,770 - $3,139	-100 Reduced 12.5%	700 $1.26 Million

3,293

3.66B

96M

121M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $139B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Uhlmann Price Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Uhlmann Price Securities, LLC with notifications on news.